The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.
Bronze - Individuals: litigation
As “the firm of reference for multinational patent holding companies, particularly in the pharmaceutical sector”, Clifford Chance seamlessly integrates local and international perspectives to adeptly handle complex cross-border litigations. It has earned acclaim as the trusted legal counsel for numerous blue-chip healthcare and life sciences clients, thanks to its high-quality services. Heading up the IP group, Miquel Montañá commands respect within the Spanish market, particularly for his expert handling of multi-jurisdictional patent disputes. His recent pivotal role in advising Nokia on a multi-jurisdictional patent enforcement proceeding in Spain against two major Chinese mobile manufacturers is testament to his prowess. Assisting him on this matter is IAM Patent 1000 newcomer Laura Cachón, an expert litigator, problem solver and trusted partner to many pharmaceutical companies. Her excellence in complex disputes, particularly focusing on patent validity and infringement, enhances the outfit’s capabilities. Adrián Crespo Velasco comes highly recommended for his strategic approach and profound technical acumen when tackling complex litigations in the pharmaceutical space. His astute advice has been instrumental in achieving a favourable outcome for Illumina, a US biotechnology company, in patent infringement proceedings against MGI Latvia Tech SIA and Commercial Rafer. Collaborating closely with him on this is the co-head of the technology practice, Josep Montefusco, whose deep expertise shines in his provision of advice to Edwards Lifesciences in patent infringement proceedings against an Indian competitor. The number of asserted patents in this is unusual, making it particularly complex to navigate. Also playing a key role in this matter is Ana Benetó, who makes her first appearance in the guide this year. She is appreciated for her strategic counsel to international companies on IP rights, with a special emphasis on patents. Popular among pharmaceutical players, she frequently advises on patent infringements against generic drug companies.